Monday, March 04, 2024

Trump’s White House Was ‘Awash in Speed’ — and Xanax

Noah Shachtman and Asawin Suebsaeng
ROLLING STONE
Sun, March 3, 2024


If you ever looked at the actions of the Trump White House and wondered, ‘Are they on drugs?’ — the answer was, in some cases, yes. Absolutely, yes.

In January, the Defense Department’s inspector general released a report detailing how the White House Medical Unit during the Trump administration distributed controlled substances with scant oversight and even sloppier record keeping. Investigators repeatedly noted that the unit had ordered thousands and thousands of doses of the stimulant modafinil, which has been used by military pilots for decades to stay alert during long missions.

The report didn’t say why so many of those pills had been given out. But for many who served in the Trump White House, the investigation highlighted an open secret. According to interviews with four former senior administration officials and others with knowledge of the matter, the stimulant was routinely given to staffers who needed an energy boost after a late night, or just a pick-me-up to handle another day at a uniquely stressful job. As one of the former officials tells Rolling Stone, the White House at that time was “awash in speed.”

Knowledgeable sources say that samples of the stimulant were passed around for those contributing lines to major Trump speeches, working late hours on foreign policy initiatives, responding to Special Counsel Robert Mueller’s probe, coping with the deluge of media inquiries about that investigation, and so much more. (Trump’s campaign did not respond to an email seeking comment for this story.)

Modafinil — also known by its brand name, Provigil — wasn’t the only controlled substance that Trump officials young and old routinely acquired. “It was kind of like the Wild West. Things were pretty loose. Whatever someone needs, we were going to fill this,” one source with direct knowledge of the matter recalls.

The anti-anxiety medication Xanax was also a popular, easy-to-get drug during the Trump years, three sources tell us. Neither Xanax nor its generic, alprazolam, is mentioned in the Pentagon report, which notes that it is not a comprehensive list of the controlled substances ordered during the Trump years. Two people with direct knowledge of the situation recall senior officials getting Xanax from the White House Medical Unit — and sharing it with colleagues.

The Trump administration was well known for its chaotic, often-erratic approach to policymaking — and for its atmosphere of paranoia, where staffers regularly spilled their colleagues’ secrets and bureaucratic factions often spent as much energy attacking one another as addressing matters of state. It’s impossible to know how much of that was fueled by the widespread availability of drugs like Xanax and Provigil. But what’s clear is that there was a breakdown of medical standards and safeguards at the highest levels of the American government; some staffers even believed that confidential information about their mental health was at risk. With Trump pushing to return to power on an agenda even more vicious than his first, a full accounting of the misuse of powerful stimulants and sedatives by his staff isn’t just a matter of historical interest. It’s a preview of a very possible future.

During Trump’s presidency, two sources say, senior staffers would repeatedly down Xanax with alcohol. Such a combination increases the risk of “serious, life-threatening side effects,” according to the National Library of Medicine. Nevertheless, senior officials would use Xanax and alcohol together to soothe themselves while enduring the sky-high levels of stress that come with working at the highest pressure environment job in America — with the added pleasure of serving the whims of the infamously volatile, intemperate Trump.

As one former senior administration official puts it: “You try working for him and not chasing pills with alcohol.”

THE WHITE HOUSE MEDICAL UNIT has been handing out prescription medications to staffers for decades — especially when they’re traveling abroad, and need to combat jet lag. “I think any White House staff knows that overseas trips are very grueling,” Stephanie Grisham, Trump’s former White House press secretary, recalls. “For us, you’d be on a flight with a president who never sleeps, and then you hit the ground running in a foreign country, and you have to be alert and ready for the president and other foreign leaders.”

She describes a procedure broadly familiar to staffers across administrations: On overseas trips, physician to the president Dr. Ronny Jackson “would come around Air Force One asking Donald Trump’s senior staff if they needed anything. This included Provigil and [the sleep aid] Ambien, and he would hand them out, typically in the form of packets with two or three pills in them. When this happened on Air Force One, a nurse would be trailing him, writing down who got what.”

It’s back home where things got sloppier, the Defense Department investigation and our sources note. Pills were often handed out without a specific need or diagnosis. Black-and-white procedures that doctors and pharmacists routinely follow when prescribing controlled substances were ignored. Orders for pills were often written down incorrectly, or not at all. One former White House Medical Unit staffer told Pentagon investigators that the unit “work[ed] in the gray… helping anybody who needs help to get this mission done.” Another said, “Is it being done appropriately or legally all the time? No. But are they going to get to that end result that the bosses want? Yeah.”

So while prescription drugs have long been in the White House — John F. Kennedy reportedly took a cocktail of uppers and downers to fight back pain, and Richard Nixon allegedly took an anti-epileptic drug “when his mood wasn’t too good” — they have rarely been dispensed as widely as they were in the Trump years.

Then-President Donald Trump participates in a briefing at the White House on April 21, 2020.

The anything-anytime-anywhere approach inspired a sense of entitlement among Trump staffers. Some senior administration officials would casually mention their Xanax intake, one source with direct knowledge of the matter recalls. The source describes a time when an aide to Melania Trump walked into the White House Medical Unit and said, “‘Could you prescribe me Xanax.’ She just came in and demanded it.” The source wasn’t a doctor or pharmacist, however, and wasn’t allowed to prescribe the anti-anxiety drug. The source politely turned the aide down. “She stormed out,” the source says.

This is not, to put it mildly, how these drugs are ordinarily handled. “We tightly track controlled substances like this because they’re addictive or can cause overdoses,” says Dr. Beata Lewis, a psychiatrist based in Brooklyn. “It sounds like with all of these substances, people could get whatever they wanted. That puts people at risk for addiction.”

She adds: “The significant thing is these rules apply to everyone … except for the White House. It’s a culture of entitlement and being above the rules to the point of putting people in danger.”

There wasn’t much the medical unit staffers could do, even if they wanted to hold the line. Several told Pentagon investigators “they feared they would receive negative work assignments or be “fired” if they spoke out.

ADDING TO THE CLIMATE OF FEAR was the sense that even private therapy sessions would not be kept private in the Trump White House. The medical unit provided psychological counseling on request. But White House staffers were instructed to be on their guard. One former senior administration official tells Rolling Stone that within the first two years of the Trump presidency, they were warned by a colleague against divulging anything during a private White House medical session that they “would not want to be used against” them. At the time, this source notes, this puzzled the official, who was then told that under Trump, the office had a reputation for being more porous with private information “than you might expect.”

The former administration official didn’t think much of it at the time. The source shrugged the warning off as mere gossip and moved on. However, according to other individuals with intimate knowledge of the matter, it was hardly an idle rumor. Immediately after counseling sessions, therapists were pressed for information about what they were told.

“They’d say, ‘We need you to see this person.’ They’d walk me over there. I’d see this person. Then as soon as I got out, they would ask, ‘Hey what happened?’” one of these sources tells us. To this source, this was a blatant violation of patient confidentiality. The source would try to be as vague as possible in their responses to the questions, but in the Trump White House, “it was all kind of open kimono,” they say.

Keith Bass, who led the White House Medical Unit from 2017 to 2019, confirms that these sorts of debriefs did, in fact, happen after counseling sessions. But he says they never went into details; they were merely to determine whether a “medical/behavioral health event” would prevent a “military/DoD staff” member “from performing their duties or impac[t] their ability to maintain a [top secret] clearance while assigned to the White House,” Bass says in an email. “Detailed clinical notes were not required from the psychologist; only a broad overview to determine fitness for duty status.”

Our source says that’s not entirely accurate. For starters, these debriefs happened after therapy sessions with civilian staffers as well. And while the questions may have been “seemingly innocent,” the source says they could be seen as the start of a “slippery slope,” which would then “drif[t] down into asking for information that was not appropriate.”

The White House Medical Unit’s often casual approach to giving out controlled substances didn’t exactly inspire confidence. “The sloppiness around handing out medications had me highly concerned about the protection of behavioral health information — medical information at large. There was no protection of sensitive patient information, period,” the source says.

Any attempts to add more rigor were entirely unwelcome, the source adds. “The more I held to professional standards” — the more the source objected to the pressure to divulge details about therapy sessions, and to keep patient information private — the worse it got. White House staffers “ostracized me,” the source says. “Nobody would talk to me. The culture was toxic as fuck.”

MODAFINIL WAS DISCOVERED in the 1970s by French scientists and was first handed out to pilots to help keep them awake and on task in the 1991 Gulf War. The U.S. military started to use modafinil in earnest around the 2003 invasion of Iraq. At the time, it was heralded as a massive improvement over previous stimulants: stronger and more effective than caffeine, less physically addictive than amphetamines. “These medications aren’t stimulants like the old military ‘go pills,’ there are few if any side effects when taken as prescribed. They simply stave off drowsiness until the medication wears off, then you naturally fall asleep,” one knowledgeable source writes.

But that “taken as prescribed” caveat is crucial. When handed out willy-nilly, outside a doctor’s supervision, modafinil can pose serious risks, notes Dr. Rachel Teodorini, a researcher at London South Bank University’s division of psychology who has examined the drug and its effects. “If people have cardiovascular problems, heart problems, or blood pressure issues, it could cause things like strokes or heart attacks,” she tells us. And while modafinil doesn’t appear to physically hook patients, “there’s an element of at least psychological dependence. Tolerance builds up, and you need more and more.”

Modafinil tablets.

As a recent study in the journal Military Medicine notes, “although modafinil was initially said to comprise no risk for abuse, there are now indications that modafinil works on the same neurobiological mechanisms as other addictive stimulants.”

And just like with other stimulants, the overuse of modafinil can lead to the perceived need for anti-anxiety medications like Xanax. “Effectively, you’re using one drug to get you up and another to get you down,” Teodorini said.

Some former Trump staffers tell Rolling Stone they didn’t get these drugs directly from the White House Medical Unit. One former Trump White House aide concedes they “borrowed” some modafinil from “a friend,” who said they’d gotten it from the unit. “I had a lot going on in my life and I wanted some,” they say.

In other administrations, modafinil was used “99 percent of the time” for jet lag, one source notes. The Trump White House was a free-for-all. Two other sources each independently compared the White House during those years to college campuses where students cramming for finals or pulling all-nighters would pass around Adderall and other drugs, prescriptions be damned. But it wasn’t just the administration’s junior staffers — the recent college grads — who partook. The sources add that midlevel and certain senior officials — including those who reported to then-President Trump and First Lady Melania Trump — came to rely on modafinil, as well. The sources and former senior Trump officials, who all requested anonymity to discuss sensitive matters, recall instances of staff casually slipping the medical unit-provided stimulant to one another, in efforts to stay focused and help navigate the exhausting chaos of the Trump presidency.

It was “ironic” that Trump’s White House was “one place the war on drugs wasn’t being fought,” one of the former officials sardonically notes, given Trump and many of his lieutenants’ zeal for waging the international war on drugs.

NEARLY EVERY SOURCE INTERVIEWED for this story traced the problems with the White House Medical Unit back to Jackson, who joined the team during the George W. Bush administration and became physician to President Barack Obama in 2013. Before then, he was known as an eccentric. Afterward, he became a menace, as several Defense Department investigations detail.

On a trip to Argentina in March 2016, one of those reports notes, Jackson’s “intoxicated behavior in the middle of the night, pounding on [a female subordinate’s] hotel room door, screaming, yelling, and overall loud behavior in his hotel room exhibited less than exemplary workplace conduct while on official travel to provide medical care for the President.” The Pentagon interviewed 60 of Jackson’s former subordinates; 56 “experienced, saw, or heard about [him] yelling, screaming, cursing, or belittling subordinates.” During a six-week stretch in 2018, a Defense Department hotline received 12 complaints” about Jackson.

Jackson’s office did not respond to a request for comment. After this story was published, he complained on X that Rolling Stone is “nothing but a liberal rag,” and demanded the names of our sources.

His nomination to become Secretary of Veterans Affairs that same year was derailed over accusations he handed out pills to White House staffers like a “candyman.” (In one case, a Senate report noted, medical staffers fell “into a panic” because he had given such “a large supply” of Percocet pain pills to a member of the White House Military Office.)

Then-President Donald Trump looks to White House physician Ronny Jackson during an event at the White House on Aug. 3, 2017.

Jackson briefly returned to the White House as Trump’s “chief medical adviser” in 2019 before running for Congress. But no matter what position he held, several sources tell us, his influence dominated medical care at the Trump White House, and Jackson’s “minions” and “loyalists” ran the White House Medical Unit in his stead. “Any practices existing at that time were all set up by Jackson, who’d been there for a dozen years. Though the med unit was led by an administrator, little happened without his say-so,” one of those sources say.

The source adds, “Unit leadership did slowly start making appropriate changes, but due to [the] complicated nature of missions, individual expectations within the organization, a self-imposed cone of silence and fear of being held liable for sins of the father, it took a long time to find the right way forward.”

OUR INTEREST IN THIS STORY was sparked, in part, by a handwritten ledger reprinted on page 14 of the January inspector general’s report: a tracking form for the controlled substances ordered by the White House Medical Unit. In addition to the thousands of pills of Ambien and Provigil listed are even more potent sedatives and pain pills: morphine, hydrocodone, diazepam and lorazepam (better known by their brand names, Valium and Ativan), fentanyl, and even ketamine.

Jackson, now a Republican congressman from Texas, told the Washington Post that his team prescribed narcotics “less than five times” across his tenure. And according to the paper’s sources, drugs like fentanyl were “kept on hand for extreme emergencies — such as a White House fence jumper impaling themselves on a spike.”

That’s a ridiculous example, a well-placed source tells us. “Someone just made up something. If there was a jumper, someone would call 911,” the source says. The jumper would then be transferred to a nearby civilian hospital.

But there was a grain of truth to the idea that the medical unit retained fentanyl and the like for extreme events. In the wake of the wars in Iraq and Afghanistan, there was a desire to bring the advances in battlefield medicine to the White House. If the president or vice president were to get shot in a remote location, far from any hospital, the unit’s physicians wanted to be able to insert a breathing tube into the VIP almost instantaneously, a process known as “rapid sequence induction and intubation.” Doing that requires sedating the patient in a hurry with powerful drugs.

“The unit employed the world’s standards in pre-hospital trauma care, as directed by the DoD’s Joint Trauma System & Committee on tactical-combat casualty-care guidelines. That includes the use of ketamine, fentanyl, etc. for pain management,” a second knowledgeable source writes. “The whole mission is contingency planning for providing most/best possible care for the worst/craziest scenarios.”

Needless to say, they never encountered a scenario that nuts. And we didn’t uncover any evidence that ketamine or fentanyl were handed out to White House staff the way Xanax and Provigil were.

But as the handwritten ledger shows — and our sources confirm — the medical unit’s procedures had grown so sloppy, so lax, that it’s impossible to prove the negative, that these sedatives and dissociatives weren’t given to White House staff. “In our analysis of the White House Medical Unit’s controlled substance records, we found that medications, such as opioids and sleep medications, were not properly accounted for,” the inspector general’s report reads. “These records frequently contained errors in the medication counts, illegible text, or crossed-out text that was not appropriately annotated.”

That might sound like minor errors in paperwork. They’re not. They’re the kind of transgressions that turn patients into addicts, and doctors into ex-doctors. “If you’re sloppy even a little bit with controlled substances, you’ll lose your [medical] license,” one source notes. Without proper record keeping, there’s no way to say just how much of the Trump White House was on drugs. There’s no way to tell how they might use — and abuse — prescription medications if they come back to power. “Nothing is written down,” another source says of the unit’s drug distribution during the Trump years, “because we will always get to yes.”
Jill Biden puts Donald Trump on notice as her campaign role comes into focus


Arlette Saenz and Betsy Klein, CNN
Sat, March 2, 2024

First lady Dr. Jill Biden isn’t holding back as her role in her husband’s reelection campaign comes into sharper focus.

Though the first lady has offered critiques of Republicans and former President Donald Trump in the past, her remarks at an Atlanta event Friday to mobilize female voters marked a clear shift – and her willingness to take the gloves off.

“I’ve been so proud of how Joe has placed women at the center of his agenda. But Donald Trump?” the first lady said to boos. “He spent a lifetime tearing us down and devaluing our existence. He mocks women’s bodies, disrespects our accomplishments and brags about assault. Now he’s bragging about killing Roe v. Wade.”

The first lady continued: “He took credit again for enabling states like Georgia to pass cruel abortion bans that are taking away the right of women to make their own health care decisions. How far will he go? When will he stop? You know the answer: He won’t. He won’t.”

As the first lady embarks on a three-day, four-stop battleground state campaign swing, launching the “Women for Biden-Harris” coalition, her role in the reelection effort is becoming clearer. The campaign is looking to use a top surrogate to organize – and mobilize – female voters heading into the general election, all while delivering a clear message about Trump.

“Donald Trump is dangerous to women and to our families. We simply cannot let him win,” she said in Atlanta.

The first lady is also traveling through Arizona, Nevada and Wisconsin, and she’s expected to court Black and Latino communities as the campaign looks to make inroads with those key demographic groups.

Much of the first lady’s work in the early stages of the campaign has focused on crisscrossing the country for fundraisers, but in the months ahead she’s expected to become a more frequent presence on the trail advocating on behalf of her husband and his agenda.

The first lady has long said that she’s not a political adviser to the president, instead explaining to CNN that she helps her husband by relaying what she sees and hears from people on the road. But she is his most trusted partner and holds influence in the White House and campaign. She sits in on some of the president’s political meetings and hiring decisions for some key staff, sources familiar with the matter said, and is eager to hit the road to push for a second Biden term.

The first lady is juggling her campaign work with her official role and her full-time teaching job at Northern Virginia Community College. While she took a break from teaching for part of 2020 to focus on the campaign, there’s no indication just yet that she’s decided to do the same this year. The campaign is looking to hire staff to support the first lady as she ramps up her outreach, a source familiar with the plans said.

A majority of her travel in 2024 will be stateside with campaign season in full swing, but it’s possible she could travel alongside the president to the G7 summit in Italy in June, as well as attend the Paris Olympics, according to a source familiar with her plans.

How to use a less-divisive Biden

Jill Biden was an active surrogate on behalf of her husband in 2020 and campaigned for Democratic candidates down the ballot during the 2022 midterm elections. As she’s traveled the country to promote the administration’s initiatives, she’s appeared in a mix of red states and more moderate areas and is expected to take a similar approach in 2024.

“She’s not going to just go to deep, deep blue areas. She’s going to go to a variety of areas in this country,” a source familiar with the planning said.

Biden campaign advisers believe the first lady’s appeal has far reach – particularly with women and grassroots supporters and in moderate parts of the country.

“The first lady’s trusted voice has been critical in reaching the voters who will decide this election. As a mom, grandmother, and educator, the first lady is uniquely able to reach and relate to core constituencies and effectively communicate the President’s message to the American people,” Biden campaign manager Julie Chavez Rodriguez told CNN in a statement.

Like many first ladies who have come before her, Biden is making her pitch as a surrogate who is significantly more popular than her husband. A recent CNN poll conducted by SSRS found that 59% of respondents had an unfavorable opinion of the president, compared with 30% who viewed the first lady unfavorably. As a less polarizing and relatable figure, the first lady is now being deployed to sell her husband’s policies and candidacy to the critical coalition of women that he’ll need once more in November.

Female voters made up a key part of the president’s 2020 coalition – he won 57% of female voters, who made up 52% of all voters in the 2020 election, according to CNN exit poll data.

“Women for Biden-Harris” is the first coalition effort the campaign has launched as it hopes to use the days around Super Tuesday to mobilize voters. The women-focused effort will include organizing calls from campaign surrogates and digital ad buys targeted toward women. This will include digital ads from the first lady’s swing, marking the first time she and her campaign work will be a central focus of an advertising push this cycle.

The push for female voters was on display in Atlanta on Friday as the first lady encouraged women to use their voices to organize heading into November.

“We’re going to do what we did in 2020 and 2022. We’re going to talk to our friends, and we’re going to tell them why this election is so important. We’re going to tell them what’s at stake. Sign up for phone banks and canvassing shifts. We’re going to meet this moment as if our rights are at risk because they are. As if our democracy is on the line, because it is,” she said.

Dr. Biden, who is the first presidential spouse to keep her full-time job teaching English at a community college, often approaches her speeches from that teaching experience, trying to distill policy issues for voters in “real terms.” She’s also expected to leverage her personal background as a working mother and grandmother to connect with female voters, tapping into common threads in their lives to talk about the power of women.

“Here’s the thing about men like Donald Trump - they underestimate our power because they don’t understand it,” she said in Atlanta. “They see us working night shifts and making grocery lists, driving to soccer practices and volunteering, caring for parents and raising money for those in need, and they think we can be ignored. They don’t know that our to-do lists are our battle maps.”

“When our daughters’ futures are at stake, when our country and its freedom hangs in the balance, we are immovable and unstoppable,” she added.

On Saturday, the first lady was confronted with an issue that has caused frustration within parts of the Democratic Party – the president’s handling of the Israel-Hamas war. She was interrupted several times by pro-Palestinian protesters as she spoke in Tucson, Arizona, at an event for Arizona List, which works to elect Democratic women who support abortion rights.

Taking on Trump


Jill Biden’s willingness to hit the campaign trail aggressively – and to support a reelection campaign, her husband’s fourth and final presidential bid – stems in part from the president’s predecessor and expected opponent, she told journalist Katie Rogers in an interview for her book, “American Woman,” which explores the role of the modern first lady.

“I would rail against injustice if I feel like somebody who would be Joe’s opponent would not be a good thing for this country,” the first lady told Rogers when asked about Trump being the possible Republican nominee. “I think I would work even harder.”

As she prepared for her first speech of this week’s campaign swing, the first lady specifically wanted to tap into the feelings many Democrats had when Trump beat Hillary Clinton in the 2016 race to remind voters about what’s at stake in November’s election, a source familiar with her thinking said.

“We can’t wake up on November 6 like we did in 2016 terrified of the future ahead of us, thinking, ‘My God, what just happened? What are we gonna do now?’’” she said. “We must reelect Joe Biden and Kamala Harris.”

Many of her critiques of her husband’s predecessor this campaign season have come in off-camera fundraisers. In one of her first fundraisers of the campaign, she expressed shock that Republicans appeared to continue supporting the former president as he faced his first indictment.

In the hours after Trump called on Republicans in a social media post to block the president’s hard-fought bipartisan border package this year, Jill Biden fired back, telling a group of donors in Houston, “Trump is trying to do everything he can to make Joe look bad, you know, even at the lives – sacrificing lives of so many people just for his own political gain.”

The first lady, a fierce defender of the president, has also pushed back on other critiques of her husband, including from special counsel Robert Hur, whose report questioned the president’s mental faculties while noting that he couldn’t remember the year their son Beau Biden passed away from brain cancer.

That detail struck a nerve with the Biden family, and the campaign channeled the first lady’s frustration into an email sent in her name to defend her husband and call out “inaccurate and personal political attacks against Joe.” The personal missive, which only featured a donate button at the end and did not include a specific contribution ask from the first lady, became the campaign’s second most lucrative email since the president’s launch announcement.

Influence and issues

With her efforts on the trail, Jill Biden joins a long line of first ladies who have campaigned for incumbent presidents seeking a second term. That role comes with an inherent ability to influence public perception of their husbands.

“A first lady definitely has that opportunity and privilege, really, to soften the messages – even the hardest messages,” said Anita McBride, who served as a top aide to former first lady Laura Bush.

Biden is confronting challenges to women’s health care and reproductive rights, an issue her husbad’s campaign is making a centerpiece of its strategy to attract moderate voters.

While Vice President Kamala Harris is the administration’s lead voice on the topic, the first lady is also using her platform, meeting with women affects by the Supreme Court’s Dobbs decision that overturned Roe v. Wade and extending an early invitation to the State of the Union address to Kate Cox, the Texas mother of two who had to leave her state to seek an abortion to end a life-threatening pregnancy. She’s spoken about abortion in personal terms, recounting how she helped a high school friend recover from an abortion in the era before Roe v. Wade.

“Women will not let this country go backwards,” the first lady said. “We’ve fought too hard for too long. And we know that there is just too much on the line.”

She approaches the conversation from a practical, less political standpoint.

“It’s just the nature of the job of first lady – that is probably the only person who’s campaigning for the president that could really find the windows of opportunity to rise above the politics, turn down the heat a little bit, appeal to people’s sensibilities and compassion for each other,” McBride said, adding that Biden is able to speak to more controversial issues such as abortion in a “humanizing way, and just a less combative way” than elected politicians.

The first lady is also looking for ways to interact with people in the community, aside from formal events and campaign speeches.

Before leaving Atlanta on Friday, she visited 3 Parks Wine Shop, a small business owned by a Black woman, to hear about its work and the neighborhood while also partaking in a wine tasting.

The first lady decided to take two bottles – a red and a white – for the plane ride out West. And as the group members sampled a sauvignon blanc, they raised their glasses to a campaign season toast: “To 2024.”

Chinese-made phones are calling the shots in Africa as they beat global giants Samsung and Apple

South China Morning Post
Sun, March 3, 2024 

Along the bustling Luthuli Avenue in downtown Nairobi, banners and billboards advertise mobile phones to the throng of shoppers passing by.

The blue, red, black and white storefronts in the busy Kenyan shopping district denote the colours associated with some of Africa's bestselling phone brands - Tecno, Infinix and iTel.

They are all phones that are made in China. But most people in mainland China will not have heard of them. After all, they have never been sold there.

Do you have questions about the biggest topics and trends from around the world? Get the answers with SCMP Knowledge, our new platform of curated content with explainers, FAQs, analyses and infographics brought to you by our award-winning team.

That is because all three phone brands are manufactured by Transsion, a Shenzhen-based company that made its fortune exclusively selling phones in Africa - before it expanded into other markets such as Latin America, India, Eastern Europe and Southeast Asia.

In fact, Transsion has made such a success of its sales strategy that in 2023 its Tecno brand sold more smartphones in the Middle East and Africa than Samsung or Apple.

It is a feat that has helped cement Chinese tech diplomacy in the region - and has in turn attracted a growing number of Chinese technology firms into Africa and the Middle East.

Tecno smartphone shipments grew by 77 per cent year on year in the fourth quarter of last year, surpassing Samsung to lead the Middle East and Africa region for the first time, according to data from Hong Kong-based firm Counterpoint Research.

During the same period, Tecno's smartphone shipment market share increased to 20 per cent from 15 per cent in 2022, while Samsung's market share dropped from 24 per cent in 2022 to 18 per cent.

According to Counterpoint, Tecno's growth was driven by handsets in the US$150 price band, with models such as the Tecno Pop 7 and the Camon 20 Pro proving popular with consumers.

Economic factors may also have played a part in Transsion's 2023 success, according to Yang Wang, a senior analyst at Counterpoint Research. He said the growth - seen particularly by Tecno - was mainly due to a much better macroeconomic environment, as inflation and energy prices came down, while local African currencies stabilised across most countries.

Wang said this had a sizeable effect in boosting consumer confidence, particularly among the lower-income audience.

"Transsion brands benefited the most from these tailwinds as they are the most invested in Africa's mid-to-lower tier smartphone segments, among the biggest brands," he said.


Sell quality phones in the budget segment, such as this Tecno Spark 8c, has been a winning formula for Transsion. Photo: Shutterstock alt=Sell quality phones in the budget segment, such as this Tecno Spark 8c, has been a winning formula for Transsion. Photo: Shutterstock>

The company's products in the affordable segment have been a key part of its success. Looking at African sales alone, Tecno had already managed to pass Samsung back in 2020. That was largely due to the successful launch of phone models in the lower price band, as well as continued market spending.

Wang said Tecno was notable in its continued investments in marketing and channel penetration, as well as ambitious plans to launch premium-grade smartphones such as foldables, which increased the brand's credibility among audiences.

It is a strategy that has worked. Transsion is now the dominant mobile phone manufacturer through the entire Middle East and Africa region, taking more than 36 per cent of the shipments market share in the fourth quarter of 2023 and 32 per cent across the whole year.

Together, Tecno, Infinix and iTel accounted for 48 per cent of the smartphone market in Africa in 2023. Tecno alone held 26 per cent of the African smartphone market share while Infinix and iTel had 12 per cent and 10 per cent market shares respectively.

For more than a decade, Transsion, which is listed on the Star Market section of the Shanghai Stock Exchange, made its money by exclusively selling its mobile phones in Africa. But in recent years it has expanded into other markets.

Its success has been attributed to superior marketing and understanding consumer needs, such as making dual SIM card phones and camera phones better calibrated for darker skin tones.

According to technology research firm International Data Corporation (IDC), Transsion shipped 95 million smartphone units last year - 30.8 per cent more than it did in 2022. IDC said Africa was the biggest contributor to Transsion's entry into the top five worldwide vendors for the first time.

Meanwhile, South Korea's Samsung ranks second with a market share of 16 per cent in Africa, though sales remained flat in 2023.

Besides Transsion, other Chinese mobile phone brands include Xiaomi and Oppo. Xiaomi, one of the top-selling Chinese smartphones globally, had a 7 per cent market share in Africa in 2023, mainly due to widening product availability and geographic reach. Oppo had a 5 per cent smartphone shipment share in Africa.

But Transsion did not start big when it entered the African market in 2008. Back then, when it launched its operations in Kenya, its office was on the second floor of a building along that same, crowded Luthuli Avenue which these days is festooned with the company's branding and billboards.

It was from this noisy street that the company established its base to grow and expand into other markets in Africa, including setting up a manufacturing plant in Ethiopia.

Since those early days, Transsion has now moved its office to a quieter part of the city at Cardinal Otunga Plaza on Kaunda Street in central Nairobi, but it has kept the Luthuli Complex office as a service centre.


Transsion began its African trading from a nondescript office on the second floor of a building in downtown Nairobi, Kenya. It now dominates the phone market across the continent. Photo: Shutterstock alt=Transsion began its African trading from a nondescript office on the second floor of a building in downtown Nairobi, Kenya. It now dominates the phone market across the continent.
 Photo: Shutterstock>

However not all Chinese phone companies have had such sales success stories in Africa. Huawei Technologies has seen its market share in Africa drop from 10 per cent in 2019 to about 1 per cent in recent years.

"Huawei was indeed one of the biggest players in the region, but sales dropped sharply after 2020 when US sanctions starved the company from access to GMS [Google Mobile Services] and chipsets," Wang said.

"[Huawei] has been on the rebound in 2023 but now accounts for less than 1 per cent of the market."

That said, Huawei Technologies is a big player in the enterprise business in Africa, where it dominates built data centres, cloud services, networks and internet connectivity infrastructure.

Sub-Saharan geoeconomic analyst Aly-Khan Satchu said Chinese mobile phone brands "are ubiquitous across the continent".

He said this speaks to the Chinese ability to get up close and personal to its demand curve as well as the skill to price appropriately without compromising on the features suite. He added that this is not unique to handsets, but applies across the consumer space.

For Huawei, Satchu said the company is competing at higher price points - and the market at those points remains thin.

"The issue of Google Mobile Services has no doubt galvanised Huawei," Satchu said. "I give it a maximum of 24 months before Huawei provides the market with a better operating system."

New Zealand-based Kenyan technology consultant Peter Wanyonyi said accessing apps such as WhatsApp, Facebook or TikTok requires smartphones.

"That is where the likes of Tecno have found a winning formula: they provide smartphone capability at very affordable prices," Wanyonyi said.

He said this used to be Huawei's market, but ever since it got locked out of Google's Android ecosystem, the Chinese tech giant has struggled to produce smartphones that provide access to the Android ecosystem - which is what Africa's middle class runs on.

"Without an equivalent set of devices at an affordable point from Huawei, a gap opened up in the African smartphone market - and there was a market in the gap. This is what Tecno and similar phone makers have exploited to quickly eat Huawei's lunch," Wanyonyi said.

Copyright (c) 2024. South China Morning Post Publishers Ltd. All rights reserved.

Tech war: Huawei's AI chip capabilities under intense scrutiny after market leader Nvidia taps it as potential rival


South China Morning Post
Sun, March 3, 2024 

The closely-guarded semiconductor capabilities of US-sanctioned Huawei Technologies have come under fresh scrutiny after Nvidia identified the Chinese telecommunications equipment giant as a potential rival in artificial intelligence (AI) chips for the first time.

With Nvidia currently unable to ship its advanced graphics processing units (GPUs) to mainland China under Washington's export restrictions, a new AI chipset from Huawei has emerged as a replacement for the US firm's Chinese products, industry insiders and analysts say.

The Huawei Ascend 910B, already available via distributor channels on the mainland, is considered by some industry participants to be on par in terms of computing power with Nvidia's sought-after A100 data-centre GPUs. Huawei has not made any public comment on the 910B.

Do you have questions about the biggest topics and trends from around the world? Get the answers with SCMP Knowledge, our new platform of curated content with explainers, FAQs, analyses and infographics brought to you by our award-winning team.

The Ascend 910B is believed to succeed the Ascend 910, which was released by Huawei in August 2019, three months after it was put on a trade blacklist by the US Commerce Department. The chip can compete with Nvidia's A100 in terms of powering AI algorithms, according to Dylan Patel, chief analyst at San Francisco-based semiconductor research firm SemiAnalysis.


A Chinese flag is seen near the logo atop Semiconductor Manufacturing International Corp's headquarters in Shanghai. The country's top contract chip maker is said to be the supplier of Huawei Technologies' new artificial intelligence chipset, the Ascend 910B. Photo: Bloomberg alt=A Chinese flag is seen near the logo atop Semiconductor Manufacturing International Corp's headquarters in Shanghai. The country's top contract chip maker is said to be the supplier of Huawei Technologies' new artificial intelligence chipset, the Ascend 910B. Photo: Bloomberg>

"It [the Ascend 910B] is a bit above the A100 theoretically," Patel said, adding that the chip is fabricated by China's top foundry, Semiconductor Manufacturing International Corp (SMIC), on a 7-nanometre process.

US sanctions since 2019 have restricted Huawei's semiconductor development and dealt a severe blow to its smartphone business. But the Shenzhen-based company has been quietly bolstering its chip business by partnering with various domestic suppliers, according to several people familiar with the matter, who declined to be identified due to the sensitivity of the matter.

Huawei showed its resilience in August last year, when it surprised the industry with the Mate 60 Pro, the company's first 5G smartphone release since the Mate 40 series in October 2020. Sales of the new handset propelled Huawei back to the top of the domestic smartphone market earlier this year.

The SMIC-made Kirin 9000s processor that powers the Mate 60 Pro sparked intense industry speculation over how Huawei managed to overcome a blanket US chip ban.


A Kirin 9000s processor, developed by Huawei Technologies chip design arm HiSilicon, is taken from a Mate 60 Pro 5G smartphone in Ottawa, capital of Canada, on September 3, 2023. Photo: Bloomberg alt=A Kirin 9000s processor, developed by Huawei Technologies chip design arm HiSilicon, is taken from a Mate 60 Pro 5G smartphone in Ottawa, capital of Canada, on September 3, 2023.
 Photo: Bloomberg>

At the domestic release of the Ascend 910, Huawei touted the chip at the time as "the world's most powerful AI processor", fabricated by the world's top contract chip maker, Taiwan Semiconductor Manufacturing Co, using a 7-nm process.

Huawei's new AI chip appears to have emerged around the same time as the Mate 60 Pro's release last August. Chinese online search and AI giant Baidu ordered 1,600 of Huawei's Ascend 910B chips in the same month, according to a Reuters report in November 2023 that cited a source.

Two weeks before Reuters published that report, Chinese AI company iFlytek launched its Feixing One computing platform based on Huawei's Ascend chips. This means the iFlytek Spark 3.0, the firm's updated large language model (LLM), may have been developed on AI chips. LLMs are the technology used to train generative AI services like ChatGPT.

Huawei declined to comment on the matter.


Jensen Huang, the co-founder, president and chief executive of US chip design firm Nvidia, attends a session of the World Governments Summit in Dubai, United Arab Emirates, on February 12, 2024. Photo: Reuters alt=Jensen Huang, the co-founder, president and chief executive of US chip design firm Nvidia, attends a session of the World Governments Summit in Dubai, United Arab Emirates, on February 12, 2024. Photo: Reuters>

In an interview with tech media outlet Wired last month, Nvidia chief executive Jensen Huang described Huawei as a "really, really good company".

"They're limited by whatever semiconductor processing technology they have, but they'll still be able to build very large systems by aggregating many of those chips together," Huang said.

Amid the increased focus on generative AI in the past year and tighter US sanctions, Huawei and SMIC have allocated more capacity to AI chips, according to a Reuters report last month.

One GPU distributor, who declined to be named due to the sensitivity of the matter, said that the Ascend 910B is "available for order, but supply is really tight at the moment".

A server used for AI training and embedded with eight Ascend 910B cards costs around 1.5 million yuan (US$208,395), which is roughly in the same range as A100 server prices quoted in black market channels, according to a separate person familiar with the matter who also declined to be named.

Huawei has not made any comment on the Ascend 910B, despite reiterating that AI is a "key strategy" ahead of the firm's exhibition at the four-day trade show MWC Barcelona in Spain last week.

Many analysts and industry professionals are reluctant to comment on the Nvidia and Huawei showdown, although they pointed out that the US chip designer has depth in GPUs and benefits from its software ecosystem CUDA, a computing platform that allows developers to unleash the full potential of semiconductors.

"CUDA is sticky, Nvidia did all of this hard work on its own and is reaping the benefits," said Brian Colello, technology equity strategist at Morningstar. "Huawei and its software partners will need to build out an ecosystem comparable [to Nvidia's CUDA] when it comes to tools to build AI models."

Despite lagging CUDA's 2 million-strong list of registered developers, Huawei has its proprietary Compute Architecture for Neural Networks, a platform that connects Ascend hardware and software, crucial to unlocking AI computing power.

Colello said Huawei might have to make similar [big] investments in mainland China to strengthen its software capabilities. He added that perhaps other companies will work on the software libraries, while Huawei focuses on chip design.

"Huawei's strength is not in the software stack," said one Shanghai-based tech investor who requested anonymity. "The US sanctions put limits on chip performance and production yields."

Copyright (c) 2024. South China Morning Post Publishers Ltd. All rights reserved.
Canadian LNG expansion 'makes little sense,' despite U.S. pause: Study


Jeff Lagerquist
Updated Mon, March 4, 2024





























































RYDAF
-0.98%



SHEL
-1.12%



EBBGF
-0.38%



EBBNF
-0.09%



EBGEF
+0.69%



ENB
-0.23%



ENBFF
0.00%



ENBHF
0.00%



ENBMF
0.00%



ENBRF
0.00%



WDS
-1.93%



WOPEF
0.00%






























A module that arrived by ship is seen at the dock at the LNG Canada export terminal under construction in Kitimat, B.C., on Wednesday, September 28, 2022.
 THE CANADIAN PRESS/Darryl Dyck 

Expanding Canada’s liquefied natural gas (LNG) industry in response to the U.S. pause on approving new export projects is “not supported by market fundamentals,” according to the Institute for Energy Economics and Financial Analysis (IEEFA).

The U.S.-based non-profit’s findings come as a top Canadian oil and gas executive and the federal minister of energy and natural resources frame the situation as a potential opportunity to boost Canada’s share of the global trade.

“It makes little sense for Canadian industry to aggressively push more LNG into the ocean when new supply is not needed,” IEEFA energy finance analyst Mark Kalegha and LNG/gas specialist Christopher Doleman wrote in a new analysis published on Monday.

Russia’s full-scale invasion of Ukraine in 2022 sent shockwaves through the global energy market as the Kremlin cut supplies to Europe, causing price spikes, while drawing attention to national energy security concerns.

The response from the global energy industry was swift. In its 2023 World Energy Outlook, the International Energy Agency says an “unprecedented surge in new LNG projects is set to tip the balance of markets” starting in 2025. IEEFA predicts a “global LNG glut” in the later half of this decade, following a historic rise in LNG supply capacity.

Canada’s first large-scale LNG export facility in Kitimat, B.C. is nearly complete. LNG Canada, a joint venture between Shell, PETRONAS, PetroChina, Mitsubishi Corporation and Korea Gas, is expected to begin shipping fuel to Asia in 2025. Two smaller export terminals, Cedar LNG and Woodfibre LNG, are also approved for construction in British Columbia.

"The LNG Canada project in Kitimat, B.C., set to come online in 2025, will be joined by projects in Mexico, the Republic of Congo, Mauritania, Russia, Australia, and Gabon," Kalegha and Doleman wrote. "With its current capacity of 12.3 billion cubic feet per day already projected to almost double by 2028, the United States will continue to produce an abundance of LNG to supply global markets. Other major suppliers, such as Qatar, plan to boost production, and are currently building massive new projects."

Within the LNG industry, Australia's Woodside Energy Group (WDS.AX) recently said it expects consumption to rise 50 per cent over the next decade, pushing the company to consider further expansion. Earlier this month, Shell (SHEL) pared back its forecast to consumption to an increase of more than 50 per cent by 2040.

Shortly after the Biden administration’s pause was announced in January, Enbridge CEO (ENB.TO)(ENB) Greg Ebel called the situation a “second chance” for Canada, following America’s emergence as the world’s top LNG exporter over the past decade.

Federal Energy Minister Jonathan Wilkinson has said he sees “an opportunity” for Canada on the basis the industry here has already significantly lowered its emissions.

Lisa Baiton, head of Canada’s main oil and gas industry group, says she wants Canada to “leverage the hell out of” the situation by drawing attention to the country’s tough environmental standards.

“The U.S. a decade ago was nowhere on LNG. Now, they’re the largest exporter on the planet,” she told Yahoo Finance Canada in an interview last month. “That should have been Canada’s opportunity.”

On top of having to navigate “a global market awash with LNG,” IEEFA warns Canadian producers will face an uncertain outlook in Asian growth markets, while Europe cuts its gas demand in line with decarbonization goals.

“The global LNG market is currently saturated with numerous projects under construction,” Kalegha and Doleman wrote. “With a high share of uncontracted volumes, proposed Canadian projects are especially vulnerable.”


Jeff Lagerquist is a senior reporter at Yahoo Finance Canada. Follow him on Twitter @jefflagerquist.
LOOTED
The Body Shop Canada parent took revenue, left company $3.3M in debt: court docs


The Canadian Press
Mon, March 4, 2024



TORONTO — The Body Shop Canada Ltd. is seeking creditor protection and closing a third of its stores because its parent company stripped the Canadian arm of cash and pushed it into debt, according to court documents.

An affidavit published through the company's court monitor from Jordan Searle, who heads the Canadian arm, describes how troubles befell the retailer, whose parent company The Body Shop International Ltd. was bought by European private equity firm Aurelius for £207 million ($355 million).

The Body Shop Canada announced Friday it will close 33 of its 105 stores and its e-commerce operations as it seeks to restructure itself under the Bankruptcy and Insolvency Act. The news came just weeks after its parent company filed for creditor protection in Britain.

The Canadian branch had 784 workers before the filings were made and about 200 will be laid off by the end of March, according to the court documents. Twenty head office employees and two contractors had their employment terminated Friday, the documents show.

Now, the longevity of the 48-year-old international company known for its cruelty-free skin care products hinges on its ability to restructure in several markets.

In Canada, where The Body Shop has been a mall stalwart since 1980, finding a path forward could involve untangling the company's finances.

The affidavit from Searle, who has been The Body Shop Canada’s general manager since February 2023 and also runs its U.S. affiliate, said the retailer's parent company had “full control” of The Body Shop Canada’s inventory, human resources, accounts payables, cash management and information technology.

Since at least 2007, The Body Shop International used a cash pooling arrangement, where The Body Shop Canada’s funds were regularly sent to the parent company which then took care of its Canadian arm's rent and payroll obligations, Searle said.

“The cash pooling arrangement has allowed The Body Shop Canada to operate with little to no institutional debt, helping it to weather a particularly difficult period for the retail industry: the COVID-19 pandemic,” the affidavit said.

“Emerging from the pandemic, The Body Shop Canada’s performance has shown significant improvement and was on track to being cash-positive by the end of this year.”

The Body Shop Canada’s situation “deteriorated sharply” in December 2023, the affidavit said. The Body Shop International kept taking its money but wasn’t paying vendors because it said it had lost access to its financing and was slowing payments to creditors to conserve cash, Searle said.

The Body Shop International filed for administration in the U.K. on Feb. 13. Administration is a legal process that allows companies to restructure or wind down without paying off all its debts.

Asked about The Body Shop Canada's claims, a spokesperson for the joint administrators being used in The Body Shop International's U.K. proceedings said in an email the company had long used cash pooling but that process ceased at the time of the administration "with funds then remaining with each subsidiary entity."

On Monday, the Ontario Superior Court of Justice granted measures including a requirement for the company's suppliers to continue to provide the retailer goods and services while it restructures and permission for stores to cease accepting gift cards and returns.

The Body Shop Canada made about $12 million before interest and taxes in the key holiday shopping period from the start of November 2023 to the end of January 2024, which wound up with The Body Shop International, Searle said.

Searle said the parent company had taken $42.9 million from The Body Shop Canada’s accounts over that period and remitted $21.8 million for payables and payrolls.

Searle called the administration filing “quite a shock” and said the day it was made, he learned The Body Shop International would no longer continue cash pooling.

By then, The Body Shop Canada owed $3.3 million to landlords, utilities and logistics providers, insurers and marketing agencies. The Body Shop U.S. has about US$3.3 million in overdue payments, Searle said.

The Body Shop Canada felt it had to file for creditor protection last week because it was “faced with mounting debt, no prospect of assistance from the U.K. parent or Aurelius or return of its funds, and an inability to fulfil e-commerce orders,” he said.

“But for the improper withholding of the company’s funds, The Body Shop Canada would be able to pay all its obligations in full.”

The Body Shop U.S. announced it would cease operations on Friday. The Body Shop Canada is so integrated into the U.S. business that the closure will make it “exceedingly difficult” for the Canadian arm to access inventory from its shuttering U.S. warehouse and process future requests, Searle said.

The company has also lost the ability to ship to its wholesale customers, Shoppers Drug Mart and Amazon.ca.

Shoppers Drug Mart has stocked Body Shop products since last summer, when the companies announced a partnership that would see merchandise, including its popular body butters, hit 25 stores. Another 25 locations were expected to roll out products this year.

The partnership marked the first time Body Shop products were sold in Canada outside the company’s stores.

This report by The Canadian Press was first published March 4, 2024.
PM BRIAN MULRONEY RIP

How Brian Mulroney benefitted Canada: Why he went from 'great success politically' to a 'slap in the face' for Canadian voters


A Canadian expert believes Mulroney spearheaded multiple policies that present Canada still relies on, but one incident left 'a really bad mark' he couldn't recover from

THE 'GREENEST' PM 
SIERRA CLUB

'BLEEDING HEART CONSERVATIVE'
THE ECONOMIST

A RED TORY


Joy Joshi
·Writer, Yahoo News Canada
Updated Fri, March 1, 2024

A Canadian politics and government expert believes former prime minister Brian Mulroney left an impressive list of achievements by the end of his tenure at the top job, but an isolated incident involving an envelope of cash during a 1993 hotel meeting botched his record.

The expert’s analysis of Brian Mulroney’s time in the office and the controversy after comes as tributes poured in following the sad announcement of the 18th Canadian prime minister’s death made by his daughter Caroline Mulroney on X, formerly known as Twitter.



Mulroney’s popularity during his tenure as prime minister from 1984 to 1993 went from “top to bottom” despite him introducing certain revolutionary policies which may have been contentious at the time but benefitted Canada in the long run, said Nelson Wiseman, Professor Emeritus of Political Science at University of Toronto, in an interview with Yahoo News Canada.

He was the first Conservative leader since the 1880’s who led his party to two consecutive majority governments. That hadn’t happened in a hundred years since John A. Macdonald. So that’s very significant. That shows great success politically.
Nelson Wiseman, Professor Emeritus of Political Science, University of Toronto

“On the other hand, he also took his party down to defeat. In fact, after winning their most smashing victory in 1984 – no party had ever got 211 seats – his party ended up disappearing, swallowed up by the Reform Party so he went from top to bottom,” Wiseman added.


Canadian government and politics expert Nelson Wiseman weighs in on Brian Mulroney's legacy and his rating on the public popularity scale

Accolades: Free trade agreement, GST and resolving Canada’s acid rain problem


Between the record-breaking win in 1984 and his political party nearly “disappearing” starting almost 10 years later, lie the key decision making events that moved him up and down the public popularity graph among Canadians.

Mulroney negotiated free trade agreements with the United States and Mexico and introduced the Goods and Services Tax (GST) domestically, both of which were challenged at the time by various opposing interest groups but are now mainstays of the Canadian economy.

“He brought in the GST which was damaging electorally but it was the right thing to do because it got rid of a heavily distorting manufacturers sales tax,” the Free Press writer Rupa Subramanya notes in her online tribute to the late prime minister.


“People don’t like to pay taxes. So, they hated him for it but it was a good thing he did it. Because, look at how much money it generates. Can you imagine what the deficit of Canada would be now without the GST?” Wiseman shared with Yahoo News Canada.

On introducing the free trade agreement with the U.S. and Mexico, Wiseman emphasized that while the majority of Canadians, including cultural communities – especially the unions and hospital workers –- who feared private American ownership taking over, were against it, the deal was “fabulous” for Canada.

Wiseman also stressed on the crucial role played by Mulroney in helping resolve Canada’s “acid rain” problem in the '80s which goes down as a major accomplishment on his record.

“If you're eating fresh vegetables and fruits in the winter, thank Mulroney,” Subramanya wrote in her post.

Mulroney’s downfall: Quebec failure, Airbus scandal and ‘deeply unpopular’


Mulroney’s downfall was “triggered” by the “disastrous” policy defeat of the Meech Lake Accord, a series of proposed amendments to the Constitution of Canada negotiated in 1987 by then-PM Mulroney and all 10 Canadian provincial premiers to bring his home province of Quebec on board, which ultimately failed.

“What he was trying to do there was to outdo Pierre Trudeau. Trudeau got the Charter of Rights and the constitution but Quebec hadn’t agreed to it,” Wiseman explained.

“Mulroney’s plan was I’m gonna bring Quebec in and win their agreement to all of this and give them something like recognizing a distinctive signing – got all the premiers to agree – but then we got some elections and had new premiers elected who insisted on changes. So Meech Lake never passed.”

One of Mulroney’s biggest ambitions to unify the country failed utterly with the efforts almost leading to its destruction as the saga almost left Quebec separated from the rest of Canada.

“That was a big slap in the face,” Wiseman concluded.


Airbus scandal was another 'bad mark' on Mulroney's legacy


Another nail in the coffin for Mulroney’s eroding popularity was the Airbus scandal that began in the late 1980s and concluded close to 2010 with the years in between presenting Mulroney with a tumultuous round of challenges.

Initially, it was alleged that Mulroney was bribed by a German-Canadian businessman to purchase the Airbus passenger aircraft for Air Canada (when it was a Crown corporation) during his prime ministership around 1988.

In his defence, Mulroney called the allegations part of a smear campaign and sued the federal government for millions of dollars with the RCMP leading the investigation and the case being settled out of court in 1997.

“It came in unmarked envelopes and he denied that he did anything with this guy, Karlheinz Schreiber, except have coffee,” Wiseman shared with Yahoo News Canada.

However, it was later determined that Mulroney received at least $225,000 in cash, which he admitted to a public inquiry but insisted that he was no longer the prime minister of Canada at the time accepting the “envelope of cash.”

“It wasn’t bribery. He wasn’t in government but he was lobbying for Air Canada to buy Airbus which they ended up doing. So that’s a really bad mark on him as a person,” Wiseman shared.

The Oliphant Commission, not mandated to determine whether civil or criminal laws had been broken, issued a final report in 2010, stating that Mulroney had acted inappropriately in not disclosing the funds.

By the time he quit from the top job and as the leader of the Progressive Conservative Party, Mulroney was deeply unpopular, and along with his unpopularity came the aftermath which left his party in tatters.
Abortion is enshrined as a constitutional right in France after lawmakers approve an amendment

Mon, March 4, 2024



PARIS (AP) — French lawmakers on Monday overwhelmingly approved a bill that will enshrine a woman’s right to an abortion in France's constitution, a historic move designed to prevent the kind of rollback of abortion rights seen in the United States in recent years.

In an exceptional joint session of parliament convened at the Palace of Versailles, the bill was approved in a 780-72 vote. Abortion enjoys wide support in France across most of the political spectrum, and has been legal since 1975.

The vote makes France the first country to have a constitutional right to abortion since the former Yugoslavia inscribed it in its 1974 constitution. Serbia’s 2006 constitution carries on that spirit, stating that “everyone has the right to decide on childbirth.”

Nearly the entire hall in France stood in a long standing ovation, and many female legislators in the hall smiled broadly as they cheered. There were jubilant scenes of celebrations all over France as women’s rights activists hailed the measure promised by President Emmanuel Macron immediately following the Dobbs ruling by the U.S. Supreme Court in 2022.

Both houses of parliament, the National Assembly and the Senate, had already adopted a bill to amend Article 34 of the French Constitution to specify that “the law determines the conditions by which is exercised the freedom of women to have recourse to an abortion, which is guaranteed.”

In the lead up to the historic vote, Prime Minister Gabriel Attal addressed the 925 lawmakers gathered for the joint session in Versailles, and called on them to make France a leader in women's rights and set an example in defense of women's rights for countries around the world.

“We have a moral debt to women,” Attal said. He paid tribute to Simone Veil, a prominent legislator, former health minister and key feminist who in 1975 championed the bill that decriminalized abortion in France.

“We have a chance to change history,” Attal said in a moving and determined speech. “Make Simone Veil proud," he said to a standing ovation.

The lower house of parliament, the National Assembly, overwhelmingly approved the proposal in January. The Senate adopted the bill on Wednesday, clearing a key hurdle for legislation promised by Macron's government, intended to make “a woman’s right to have an abortion irreversible.”

A three-fifths majority in the joint session was required for the measure to be approved

None of France’s major political parties represented in parliament have questioned the right to abortion, including Marine Le Pen’s far-right National Rally party and the conservative Republicans. However, some lawmakers have voted against inscribing abortion right into the constitution in previous votes in both houses.

Le Pen, who won a record number of seats in the National Assembly two years ago, said on Monday that her party will vote in favor of the bill but added that “there is no need to make this a historic day.”

The right to an abortion has broad support among the French public. A recent poll showed support at more than 80%, consistent with previous surveys. The same poll also showed that a solid majority of people are in favor of enshrining it in the constitution.

There were scenes of celebrations around France even before the joint parliamentary session began.

Sarah Durocher, a leader in the Family Planning movement, said Monday's vote is “a victory for feminists and a defeat for the anti-choice activists.”

With the right to an abortion added to the constitution, it will be much harder to prevent women from voluntarily terminating a pregnancy in France, women’s rights and equality activists said.

“We increased the level of protection to this fundamental right,” said Anne-Cécile Mailfert of the Women’s Foundation. “It’s a guarantee for women today and in the future to have the right to abort in France.”

The government argued in its introduction to the bill that the right to abortion is threatened in the United States, where the Supreme Court in 2022 overturned a 50-year-old ruling that used to guarantee it.

“Unfortunately, this event is not isolated: in many countries, even in Europe, there are currents of opinion that seek to hinder at any cost the freedom of women to terminate their pregnancy if they wish,” the introduction to the French legislation says.

The decision by the U.S. Supreme Court to strip women of the right to abortion has reverberated across Europe’s political landscape, forcing the issue back into public debate in France at a time of political upheaval.

Mathilde Philip-Gay, a law professor and a specialist in French and American constitutional law, warned against easing the pressure on legislators for women's rights as far-right parties — determined to curtail women's rights — gain political influence and are elected to form governments around Europe and elsewhere.

"It may not be an issue in France, where a majority of people support abortion,” Philip-Gay said. “But those same people may one day vote for a far-right government, and what happened in the U.S. can happen elsewhere in Europe, including in France.”

Inscribing abortion into the French Constitution "will make it harder for abortion opponents of the future to challenge these rights, but it won't prevent them from doing it in the long run, with the right political strategy,” Philip-Gay added.

"It only takes a moment for everything we thought that we have achieved to fade away,” said Yael Braun-Pivet, the first female president of the French parliament, in her address to the joint session.

Amending the constitution is a laborious process and a rare event in France. Since it was enacted in 1958, the French Constitution has been amended 17 times. The last time was in 2008, when parliament was awarded more powers and French citizens were granted the right to bring their grievances to the Constitutional Court.

___

Barbara Surk reported from Nice.

Barbara Surk And Nicolas Garriga, The Associated Press



French lawmakers gather for a historic vote that will make abortion a constitutional right


BY BY BARBARA SURK, ASSOCIATED PRESS - 03/04/24 

A bill to enshrine a woman’s right to an abortion in the French constitution goes to a historic vote on Monday, as lawmakers gather for a joint session of parliament at the Palace of Versailles.

The measure was promised by President Emmanuel Macron following a rollback of abortion rights in court rulings in the United States.

Macron’s government wants Article 34 of the French constitution amended to specify that “the law determines the conditions by which is exercised the freedom of women to have recourse to an abortion, which is guaranteed.”

The lower house of parliament, the National Assembly, overwhelmingly approved the proposal in January. The Senate adopted the bill on Wednesday, clearing a key hurdle for legislation promised by Macron’s government, intended to make “a woman’s right to have an abortion irreversible.”

The measure must be approved by a three-fifths majority in the joint session.

None of France’s major political parties represented in parliament has questioned the right to abortion, which was decriminalized in 1975. With both houses of parliament having adopted the bill, Monday’s joint session at the Palace of Versailles is expected to be largely a formality.

The government argued in its introduction to the bill that the right to abortion is threatened in the United States, where the Supreme Court in 2022 overturned a 50-year-old ruling that used to guarantee it.

“Unfortunately, this event is not isolated: in many countries, even in Europe, there are currents of opinion that seek to hinder at any cost the freedom of women to terminate their pregnancy if they wish,” the introduction to the French legislation says.

France moves to make abortion a constitutional right amid rollbacks in US and Europe

The constitutional revision, backed by an overwhelming majority of the population, put conservatives and the far right in a tough spot.


The measure sailed through both chambers of the French parliament and is expected to pass | Mathilde Kaczkowksi/Hans Lucas/AFP via Getty Images

MARCH 4, 2024 
BY VICTOR GOURY-LAFFONT

PARIS — France is set to become the first country to enshrine the freedom to have an abortion in its constitution — an effort by President Emmanuel Macron to send a strong message of support for reproductive rights and, at the same time, score political points at the expense of a resurgent far right.

The amendment will be added to the French constitution if three-fifths of parliamentarians from the upper and lower houses approve the bill during an extraordinary voting session being held on Monday in Versailles.

The measure sailed through both chambers of the French parliament and is expected to pass.

Abortion rights are widely supported in France, and limiting them was not a publicly debated issue. While the French left has for years wanted to add a constitutional safeguard to an abortion, until 2022 most lawmakers believed such a move was unnecessary given the existing guarantees for women seeking an abortion.

Macron's government was spurred to action by the U.S. Supreme Court's decision to overturn Roe v. Wade, giving individual states the green light to outlaw the procedure.

“It’s impossible to tell if abortion rights won’t come into question in the future in France,” Mathilde Panot, head of the left-wing France Unbowed group in the National Assembly, told POLITICO. “It’s important to capitalize when we have public on our side.”

She said that Macron only acted thanks to “the work of feminist organizations and parliamentarians.”

“He can boast, but it’s first and foremost our victory,” Panot said.

Splitting the right

While abortion is legal in most of the European Union, right-wing populists across the bloc have implemented policies designed to restrict or make more complicated access to the procedure. In Hungary, pregnant people are made to listen to the pulse of the fetus, sometimes described as a "fetal heartbeat," a term medical professionals reject, from the very first ultrasound. Poland outlawed abortion in most cases while the right-wing Law and Justice party was in power, though new Prime Minister Donald Tusk is working on overturning the ban.

Officially, the far-right National Rally supports the right to end a pregnancy, but abortion remains a divisive topic in its ranks. Of its 88 MPs, 46, including three-time presidential candidate Marine Le Pen, voted in favor of the constitutional revision. Twelve voted against; 14 abstained.

The National Rally is currently surging in the polls ahead of the June European election. A recent poll showed the pro-Macron list for the European election 12 percentage points behind the French far-right standard bearer and only seven ahead of the Socialist-backed list led by Raphaël Glucksmann.

Macron's rightwards pivot on issues including immigration has led to concerns within his own camp of seeing the left-end of the president's voter base turning towards other options on the center-left

.
Macron's government was spurred to action by the U.S. Supreme Court's decision to overturn Roe v. Wade, giving individual states the green light to outlaw the procedure | Kiran Ridley/AFP via Getty Images

By backing a hugely popular proposal a few months ahead of an election, Macron gave conservative and far-right leaders a headache while courting support from the left.

Enshrining abortion rights into the constitution was a way of "uniting against conservatives and reactionaries," Christopher Weissberg, an MP in the pro-Macron ranks told POLITICO. "It helped build consensus and show ourselves under a progressive light."

Weissberg, who represents French citizens living in Canada and the U.S. said he had seen concern among his stateside constituents after the Roe v. Wade reversal, with some even reconsidering their future in the country

Increasing polarization

An IFOP poll from 2022 showed 81 percent of respondents in favor of adding the right to have an abortion to the constitution, with majority support across party lines. Only 10 percent said they had a negative opinion on abortion being legal.

"When abortion was legalized [in 1975], the French population was split on the matter," Pierre-Hadrien Bartoli, an analyst for the OpinionWay polling institute, said, pointing to the much higher prevalence of religious practice then compared to the now widely secularized French society. "The opinion that it [abortion] should be banned in all cases has almost disappeared.”

The increasing polarization of France's politics occasionally led the issue to reappear in the public debate. CNews, a news channel owned by the devout Catholic billionaire Vincent Bolloré and often compared to America's Fox News, recently showed a graphic presenting abortion as the first cause of mortality worldwide. The channel later apologized for doing so.

The French conservative movement, Les Républicains, also had doubts. François-Xavier Bellamy, its lead candidate for the EU election, said in a 2019 interview he was "personally" against abortion and had taken part in anti-abortion protests in the past. Gérard Larcher, also a member of Les Républicains and the president of the conservative-controlled Senate, said he was against granting abortion a constitutional status, arguing that "abortion is not under threat in France."

Many opponents of the constitutional revision echoed his sentiments, stressing that their opposition was on legal or procedural grounds and that they did not seek to outlaw abortions.

"Macron forced Les Républicains to adopt a stance on an issue on which a wide array of opinions exist within the party," Bartoli said. For the far-right National Rally, the challenge is "keeping the image of a firm opponent" without alienating its base which, in majority, "will cheer on the proposed change," he added.